Zimmer Biomet Holdings

NYSE
ZBH
Stock
Yield per half year: -10.95%
Dividend yield: 0.9124%
Sector: Healthcare

Company Analysis Zimmer Biomet Holdings

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (-8.3%) is higher than the sector average (-47.17%).
  • Current debt level 29.04% is below 100% and has decreased over 5 years from 33.36%.
  • The company's current efficiency (ROE=7.25%) is higher than the sector average (ROE=-83.32%)

Disadvantages

  • Price (93.79 $) is higher than fair price (78.85 $)
  • Dividends (0.9124%) are below the sector average (1.28%).

Similar companies

UnitedHealth Group

Humana

Bristol-Myers

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Zimmer Biomet Holdings Healthcare Index
7 days 0.3% 0% -0.2%
90 days -1.5% -45.3% 17.5%
1 year -8.3% -47.2% 11.2%

ZBH vs Sector: Zimmer Biomet Holdings has outperformed the "Healthcare" sector by 38.87% over the past year.

ZBH vs Market: Zimmer Biomet Holdings has significantly underperformed the market by -19.55% over the past year.

Stable price: ZBH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: ZBH with weekly volatility of -0.1596% over the past year.

3. Summary of the report

3.1. General

P/E: 23.78
P/S: 2.8

3.2. Revenue

EPS 4.43
ROE 7.25%
ROA 4.22%
ROIC 2.07%
Ebitda margin 29.31%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (93.79 $) is higher than the fair price (78.85 $).

Price is higher than fair: The current price (93.79 $) is 15.9% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (23.78) is lower than that of the sector as a whole (52.65).

P/E vs Market: The company's P/E (23.78) is lower than that of the market as a whole (61.8).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.72) is lower than that of the sector as a whole (10.87).

P/BV vs Market: The company's P/BV (1.72) is lower than that of the market as a whole (20.58).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (2.8) is lower than that of the sector as a whole (4.03).

P/S vs Market: The company's P/S indicator (2.8) is lower than that of the market as a whole (15.97).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (12.07) is lower than that of the sector as a whole (16.12).

EV/Ebitda vs Market: The company's EV/Ebitda (12.07) is lower than that of the market as a whole (18.72).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -151.56% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-151.56%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).

5.4. ROE

ROE vs Sector: The company's ROE (7.25%) is higher than that of the sector as a whole (-83.32%).

ROE vs Market: The company's ROE (7.25%) is lower than that of the market as a whole (42.63%).

5.5. ROA

ROA vs Sector: The company's ROA (4.22%) is lower than that of the sector as a whole (6.38%).

ROA vs Market: The company's ROA (4.22%) is lower than that of the market as a whole (23.26%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (2.07%) is lower than that of the sector as a whole (15.06%).

ROIC vs Market: The company's ROIC (2.07%) is lower than that of the market as a whole (9.17%).

6. Finance

6.1. Assets and debt

Debt level: (29.04%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 33.36% to 29.04%.

Excess of debt: The debt is not covered by net income, percentage 686.5%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.9124% is below the average for the sector '1.28%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.9124% has been steadily paid over the past 7 years, DSI=1.

Weak dividend growth: The company's dividend yield 0.9124% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (21.69%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Zimmer Biomet Holdings

9.3. Comments